CEL-SCI Corporation Unveils Multikine Breakthrough in Head and Neck Cancer Treatment, Stock Surges
CEL-SCI Corporation revealed pivotal advancements in its immunotherapy drug Multikine (Leukocyte Interleukin, Injection) for head and neck cancer treatment, during its debut presentation at the